Licochalcone B

SKU: orb1302361

Description

Licochalcone B (LCB) exhibits antitumor activity against bladder cancer cell lines in vitro and in vivo, while both LCB and Licochalcone D (LCD) demonstrate anti-inflammatory effects by suppressing LPS-induced mediators. A novel LCB derivative further shows protective effects against endotoxin shock in mice, highlighting its potential in oncology and immunology research.

Research Area

Cell Biology, Immunology & Inflammation, Neuroscience

Key Properties

• CAS Number: 58749-23-8
• MW: 286.28
• Purity: 99.93% (May vary between batches)
• Formula: C₁₆H₁₄O₅
• SMILES: COc1c(O)c(O)ccc1\C=C\C(=O)c1ccc(O)cc1
• Target: Beta Amyloid,Apoptosis,NOD-like Receptor (NLR)
• Solubility: Chloroform, Dichloromethane, Ethyl Acetate, Acetone, etc.:Soluble;10% DMSO+90% Saline:1 mg/mL (3.49 mM);DMSO:150 mg/mL (523.96 mM)

Storage & Handling

• Storage: keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Beta Amyloid, BetaAmyloid, Abeta, b Amyloid, bAmyloid, Apoptosis, Amyloid-β, Inhibitor, Licochalcone B, inhibit, NOD-like Receptor (NLR), β-amyloid peptide, β Amyloid, βAmyloid

Compound Identifiers

PubChem CID

5318999